Pancreatic Cancer Research

ResearcherPeking UniversityNo recent work listed

Hongquan Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8193-0899; OpenAlex author ID A5100707237. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 4

  1. Acetylated HOXB9 at lysine 27 is of differential diagnostic value in patients with pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s11684-019-0696-6↗
  2. High expression of muscarinic acetylcholine receptor 3 predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Last author DOI 10.2147/ott.s111382↗
  3. Kindlin-2 induced by TGF-β signaling promotes pancreatic ductal adenocarcinoma progression through downregulation of transcriptional factor HOXB9. Last author DOI 10.1016/j.canlet.2015.02.039↗
  4. Integrin αvβ₆-Targeted SPECT Imaging for Pancreatic Cancer Detection. Co-author DOI 10.2967/jnumed.113.132969↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jun Zhan · 4 shared papers, 2014–2020 · strength 0.29
  2. Xiaoran Sun · 1 shared paper, 2020 · strength 0.13
  3. Lingfu Zhang · 1 shared paper, 2016 · strength 0.06
  4. Dianrong Xiu · 1 shared paper, 2016 · strength 0.06
  5. Zhaofei Liu · 1 shared paper, 2014 · strength 0.04
  6. Zhaohui Zhu · 1 shared paper, 2014 · strength 0.04
  7. Fan Wang · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.